HB

What this means for you

This application is over — abandoned 03 Jan 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88464386

Mark type

Design + words

Filed

07 Jun 2019

Published for opposition

08 Oct 2019

Abandoned

03 Jan 2022

Attorney of record

Donna J. Bunton

Goods and services

• Class 005 — Pharmaceuticals: Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS
• Class 042 — Scientific and technological services: Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS

Owner

• AIM IMMUNOTECH INC., OCALA, FL, US
• HEMISPHERX, Orlando, FL, US
• HEMISPHERX, Orlando, FL, US

Prosecution history

• 03 Jan 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 03 Jan 2022 — ABANDONMENT - NO USE STATEMENT FILED
• 05 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 03 Jun 2021 — SOU EXTENSION 3 GRANTED
• 03 Jun 2021 — SOU EXTENSION 3 FILED
• 03 Jun 2021 — SOU TEAS EXTENSION RECEIVED
• 02 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 30 Nov 2020 — SOU EXTENSION 2 GRANTED
• 30 Nov 2020 — SOU EXTENSION 2 FILED
• 30 Nov 2020 — SOU TEAS EXTENSION RECEIVED
• 05 Jun 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 03 Jun 2020 — SOU EXTENSION 1 GRANTED
• 03 Jun 2020 — SOU EXTENSION 1 FILED
• 03 Jun 2020 — SOU TEAS EXTENSION RECEIVED
• 03 Dec 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT